Skip to main content
NIH funding notice PAR-23-207

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

Closed on January 6, 2025.

Posted
June 14, 2023
Close date
January 6, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,291,566 in first-year total cost, median $2,145,783.

Most frequent study sections

  1. Cognitive Disorders and Brain Aging Study Section[CDBA]2

Most frequent institutions

  1. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
  2. UNIVERSITY OF FLORIDA1
Competing awards under PAR-23-207 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Promoting stress-resilience prevents AD-associated neuropsychiatric symptoms1RF1AG093281-01MOREL, CAROLE SWANG, JUNICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$3,548,990CDBA
2025Anxiety in Parkinson’s disease: using fMRI to evaluate amygdala networks in the on and off dopamine state1R01MH139576-01BAKKER, ARNOLDPONTONE, GREGORY MICHAELUNIVERSITY OF FLORIDA, FL$742,576CDBA

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.